Equity · Currency in GBp · Last updated Jun 6, 2026
Diaceutics plc, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics plc was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
DXRX.L's Sharpe Ratio of 0.20 indicates that for each unit of volatility, it generates 0.20 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 6, 2026).
Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets.
DXRX.L Sharpe Ratio Rank
Average
DXRX.L ranks above 49.4% of all investments in our database based on Sharpe Ratio over the past 12 months, showing balanced returns relative to total risk taken. Securities are ranked from 0 (worst) to 100 (best).
What moves the rank
Strong returns with low total volatility → Higher rank
High volatility (both upside and downside) → Lower rank
Consistent returns → Higher rank than volatile returns of same magnitude
Sharp drawdowns increase volatility → Lower rank
What you can do with this information
Returns are proportional to volatility—neither strong nor weak
Evaluate whether the volatility profile aligns with your risk tolerance
Review higher-ranked alternatives in the same category
Monitor rank direction to identify improving or deteriorating trends
DXRX.L Sharpe Ratio Market Positioning
The chart shows DXRX.L's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.
DXRX.L: 0.20
S&P 500 Index: 2.28
Red zone (bottom 25%): -0.40 or lower
Yellow zone (middle 50%): -0.40 to 1.11
Green zone (top 25%): 1.11 or higher
Top 1%: 5.33+
Median: 0.21 — half of all investments score higher
How it compares to other similar stocks
The table compares Diaceutics plc's Sharpe Ratio with other stocks in the Diagnostics & Research industry across multiple time periods, showing how DXRX.L's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 6, 2026.
The chart shows DXRX.L's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when DXRX.L consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
Sharpe Ratio Calculator
How does DXRX.L fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
